11.20.19
Bioanalytical Systems, Inc. (BASi), has launched its new contract research services brand, Inotiv. Inotiv represents the union of BASi’s Seventh Wave Laboratories and Smithers Avanza Toxicology Services in vivo toxicology, pharmacology, drug metabolism, bioanalysis, and pharmacokinetic (PK) solutions. The rebrand reflects the company’s increased scope of services and its resulting position as a top contract research organization (CRO) for drug discovery and development.
The combined organization provides data and insights that drug developers need, while the legacy companies’ integrated, complementary resources and capabilities offer a comprehensive service portfolio for this space.
“Developers should expect more from their laboratory partners,” said Bob Leasure, president and chief executive officer. “We provide a full range of nonclinical and analytical services and adapt them seamlessly to each client’s goals. With the timely, focused insights they deserve, clients get the answers they need to advance confidently to their next milestones.”
The rebrand of the company’s contract research services business includes a new logo, philosophy, positioning, and website. Visit inotivco.com.
The company’s products business will continue to operate under the name BASi.
The combined organization provides data and insights that drug developers need, while the legacy companies’ integrated, complementary resources and capabilities offer a comprehensive service portfolio for this space.
“Developers should expect more from their laboratory partners,” said Bob Leasure, president and chief executive officer. “We provide a full range of nonclinical and analytical services and adapt them seamlessly to each client’s goals. With the timely, focused insights they deserve, clients get the answers they need to advance confidently to their next milestones.”
The rebrand of the company’s contract research services business includes a new logo, philosophy, positioning, and website. Visit inotivco.com.
The company’s products business will continue to operate under the name BASi.
